French diagnostics spending continues to fall:
This article was originally published in Clinica
Executive Summary
French reimbursement for diagnostic tests fell 0.7% in April compared with a slight fall in March of 0.1% over the previous month. Spending on auxiliary procedures, which include EEGs and ECGs, fell 1.2% in April compared with a rise of 0.3% in March. Figures from national medical insurers CNAM show reimbursement for small equipment was Fr 89.5 million ($17.5 million) during the month and Fr 93.3 million for large equipment. April reimbursement for pacemakers was Fr 18.4 million and for other internal prostheses Fr 224.4 million. Total health reimbursement was down 0.4% for the month to Fr 35,505 million.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.